Group One Trading, L.P. Rockwell Medical, Inc. Transaction History

Group One Trading, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$1.23 - $1.86 $354 - $535	288 New	288 $0
Q2 2023 Aug 09, 2023	BUY	$1.8 - $5.46 $1,533 - $4,651	852 Added 35.54%	3,249 $17,000
Q1 2023 May 12, 2023	BUY	$1.03 - $2.62 $103 - $262	100 Added 4.35%	2,397 $4,000
Q4 2022 Feb 09, 2023	BUY	$0.84 - $1.39 $591 - $978	704 Added 44.19%	2,297 $2,000
Q3 2022 Nov 09, 2022	SELL	$1.2 - $2.11 $3,339 - $5,872	-2,783 Reduced 63.6%	1,593 $2,000
Q2 2022 Aug 11, 2022	BUY	$1.28 - $4.84 $5,601 - $21,179	4,376 New	4,376 $6,000

9.46M

339K

43.3K

Ticker RMTI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 10,675,200
Market Cap $24.9M
Description
Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iro...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.